The mutual exclusivity of FOXA1 and FOXA2 mutations in prostate cancer and EC might seem counterintuitive given that they share diverse embryonic functions and broad expression across the endoderm and its derivatives (1). This evidence concerns the gene FOXA2 and prostate carcinoma.